Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
07/1995
07/06/1995CA2180359A1 Ileal bile acid transporter compositions and methods
07/05/1995EP0660709A1 Creatine analogs having antiviral activity
07/04/1995US5429938 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
06/1995
06/29/1995WO1995017414A1 Anti-hepatitis b viral oligonucleotides
06/29/1995WO1995017378A1 Compound capable of introducing at least one molecule into a cell
06/29/1995WO1995017213A1 P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
06/29/1995WO1995017198A1 A novel tumor suppressor gene
06/29/1995WO1995017092A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η?
06/29/1995CA2179606A1 Macrophage inflammatory proteins-3, -4 and -1.gamma.
06/29/1995CA2179385A1 Compound capable of introducing at least one molecule into a cell
06/29/1995CA2178811A1 Anti-hepatitis b viral oligonucleotides
06/29/1995CA2178745A1 A novel tumor suppressor gene
06/28/1995EP0659216A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells
06/28/1995EP0659211A1 Methods and therapeutic compositions for treating cystic fibrosis
06/28/1995EP0659209A1 Cancer therapy utilizing malignant cells
06/28/1995EP0552280B1 Inhibition of viral replication
06/27/1995US5428070 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
06/27/1995US5427940 Engineered cells producing insulin in response to glucose
06/22/1995WO1995016784A1 Human interferon expression vectors for treating aids
06/22/1995WO1995016780A1 Antiviral composition of viral protein trans-dominant variants
06/22/1995WO1995016775A1 Tumor cell fusions and methods for use of such tumor cell fusions
06/22/1995WO1995016694A1 Origin of replication complex genes, proteins and methods
06/22/1995WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995WO1995016437A1 Method of transmitting a biologically active material to a cell
06/22/1995WO1995016353A1 Systemic gene treatment of connective tissue diseases
06/22/1995WO1995015381A3 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer
06/22/1995WO1995011048A3 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO)
06/22/1995WO1995009241A3 Anti-cancer gene therapy by modulation of immune or inflammatory response
06/22/1995WO1995003407A3 Oligonucleotides with activity against human immunodeficiency virus
06/22/1995CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995CA2178965A1 Origin of replication complex genes, proteins and methods
06/22/1995CA2178950A1 Tumor cell fusions and methods for use of such tumor cell fusions
06/22/1995CA2155929A1 Systemic gene treatment of connective tissue diseases
06/22/1995CA2155844A1 Antiviral composition of viral protein trans-dominant variants
06/22/1995CA2155568A1 Human interferon expression vectors for treating aids
06/21/1995EP0658209A1 Endothelial lineage specific transcriptional regulatory element from tek
06/21/1995EP0658117A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors
06/15/1995WO1995016051A2 Methods and compositions for the suppression of neu mediated transformation
06/15/1995WO1995016048A2 Recombinant protein production in bovine adenovirus expression vector system
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995014100A3 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
06/15/1995WO1995012678A3 Improvements relating to cancer therapy
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2177835A1 Methods and compositions for the suppression of neu mediated transformation
06/14/1995EP0657541A1 Novel entities for cancer therapy
06/14/1995EP0657540A1 Novel entities for cancer therapy
06/14/1995EP0657539A1 Novel entities for cancer therapy
06/14/1995EP0656948A1 $i(BORDETELLA BRONCHISEPTICA) VACCINE
06/14/1995EP0656942A1 Compositions and methods for inhibiting growth or replication of viruses
06/14/1995EP0656790A1 Compositions and methods for modulating rna
06/14/1995EP0656747A1 Composition and method for altering dna sequences by homologous recombination
06/13/1995US5424400 Senescent cell derived inhibitors of DNA synthesis
06/13/1995US5423778 System and method for transplantation of cells
06/08/1995WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995WO1995015381A2 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
06/08/1995WO1995015373A2 Inhibition of dna methyltransferase
06/08/1995WO1995015334A1 cDNA PROBE FOR BREAST CANCER DIAGNOSIS AND TREATMENT
06/08/1995WO1995015333A1 Nucleosides and oligonucleotides containing boron clusters
06/08/1995WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
06/08/1995WO1995015167A1 In utero gene therapy for fetuses
06/08/1995WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin
06/08/1995CA2617836A1 Nucleosides and oligonucleotides containing boron clusters
06/08/1995CA2177998A1 In utero gene therapy for fetuses
06/08/1995CA2177991A1 A 46 kd human milk fat globule antigen
06/08/1995CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995CA2177252A1 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer
06/08/1995CA2177031A1 Inhibition of dna methyltransferase
06/07/1995EP0656060A1 Androgen regulation with dna sequences of rat probasin gene
06/07/1995EP0656007A1 Opioid receptor genes
06/07/1995EP0655926A1 New tumor diagnosing or therapeutical probe
06/07/1995CN1028760C Process for preparing sequence of antidirection direction, antimessenger RNA oligonuclectides of alpha TNF
06/01/1995WO1995014785A1 Composition for the in vivo production of therapeutic products
06/01/1995WO1995014707A1 N-2 substituted purines
06/01/1995WO1995014706A1 Pna-dna-pna chimeric macromolecules
06/01/1995WO1995014651A1 Amphiphilic derivatives of piperazine
06/01/1995WO1995014493A1 Three-step pretargeting methods and compounds
06/01/1995WO1995014487A1 Treatment of viral disease with cd40l peptide
06/01/1995WO1995014381A1 Amphiphilic derivatives of guanidine
06/01/1995WO1995014380A1 Amphiphilic imidazolinium derivatives
06/01/1995CA2177037A1 Three-step pretargeting methods and compounds
06/01/1995CA2176715A1 Amphiphilic derivatives of guanidine
06/01/1995CA2176714A1 Amphiphilic derivatives of piperazine
05/1995
05/30/1995US5420263 Amplification of human MDM2 gene in human tumors
05/30/1995US5420026 Self-assembling replication defective hybrid virus particles
05/26/1995WO1995014102A1 Recombinant viruses coding for thymidine kinase in gene therapy
05/26/1995WO1995014101A1 Recombinant adenoviruses for gene therapy in cancers
05/26/1995WO1995014100A2 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
05/26/1995WO1995014095A1 Endothelin-converting enzyme
05/26/1995WO1995014091A2 Compositions and methods for utilizing conditionally lethal genes
05/26/1995WO1995014082A1 Delivery of gene products via mesangial cells
05/26/1995WO1995014079A1 Myocardial grafts and cellular compositions useful for same
05/26/1995WO1995014078A1 Bioengineered human blood cells
05/26/1995WO1995014031A1 Chirally enriched synthetic phosphonate oligomers
05/26/1995WO1995014030A1 Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
05/26/1995WO1995013834A1 Chimeric oligonucleoside compounds
05/26/1995WO1995013833A1 Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages
05/26/1995WO1995013701A1 Novel fas protein and methods of use thereof
05/26/1995CA2184485A1 Bioengineered human blood cells
05/26/1995CA2176585A1 Recombinant adenoviruses for gene therapy in cancers
05/26/1995CA2176575A1 Novel fas protein and methods of use thereof
1 ... 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 ... 870